Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Seminars in Nuclear Medicine|March 31, 2026
FAP in cardiovascular pathophysiology: Advances in non-invasive imaging and therapeutic targeting for myocardial fibrosisJinli Pei, Xinzhi Zhao, Yizhen Pang, et al.
Theranostics|February 24, 2022
Fibroblast activation protein-based theranostics in cancer research: A state-of-the-art reviewLiang Zhao, Jianhao Chen, Yizhen Pang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 8, 2024
Fibroblast Activation Protein Inhibitor Tracers and Their Preclinical, Translational, and Clinical Status in ChinaLiang Zhao, Fei Kang, Yizhen Pang, et al.
Biophysics Reports|January 6, 2025
Current status of FAP-directed cancer theranostics: a bibliometric analysisDan Ruan, Simin Wu, Xuehua Lin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 26, 2023
Fibroblast Activation Protein-Targeted PET/CT with 18F-Fibroblast Activation Protein Inhibitor-74 for Evaluation of Gastrointestinal Cancer: Comparison with 18F-FDG PET/CTWeizhi Xu, Jiayu Cai, Tianxing Peng, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 29, 2026
CXCR4-targeted PET/CT with [¹⁸F]AlF-NOTA-QHY-04 in primary central nervous system lymphoma: a prospective comparison with MRI and [¹⁸F]FDG PET/CTYizhen Pang, Lijie Xing, Jingru Liu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 8, 2021
Role of [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET/CTLiang Zhao, Yizhen Pang, Zuoming Luo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2022
PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using 68Ga-FAP-2286: Comparison with 18F-FDG and 68Ga-FAPI-46 in a Single-Center, Prospective StudyYizhen Pang, Liang Zhao, Tinghua Meng, et al.
Pageof 8